Keywords
Last Name
Institution

John P. O'Bryan

Title
InstitutionMedical University of South Carolina
DepartmentCell and Molecular Pharmacology and Experimental Therapeutics
AddressP.O. Box MSC 955
HO712E
Hollings Cancer Center - 86 Jonathan Lucas St.
Phone843-792-8393
Fax843-792-2475
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Khan I, Spencer-Smith R, O'Bryan JP. Correction: Targeting the a4-a5 dimerization interface of K-RAS inhibits tumor formation in vivo. Oncogene. 2019 May; 38(22):4426. PMID: 30710144.
      View in: PubMed
    2. Khan I, Spencer-Smith R, O'Bryan JP. Targeting the a4-a5 dimerization interface of K-RAS inhibits tumor formation in vivo. Oncogene. 2019 04; 38(16):2984-2993. PMID: 30573767.
      View in: PubMed
    3. O'Bryan JP. Pharmacological targeting of RAS: Recent success with direct inhibitors. Pharmacol Res. 2019 01; 139:503-511. PMID: 30366101.
      View in: PubMed
    4. Sudhahar V, Okur MN, Bagi Z, O'Bryan JP, Hay N, Makino A, Patel VS, Phillips SA, Stepp D, Ushio-Fukai M, Fukai T. Akt2 (Protein Kinase B Beta) Stabilizes ATP7A, a Copper Transporter for Extracellular Superoxide Dismutase, in Vascular Smooth Muscle: Novel Mechanism to Limit Endothelial Dysfunction in Type 2 Diabetes Mellitus. Arterioscler Thromb Vasc Biol. 2018 03; 38(3):529-541. PMID: 29301787.
      View in: PubMed
    5. Spencer-Smith R, O'Bryan JP. Direct inhibition of RAS: Quest for the Holy Grail? Semin Cancer Biol. 2019 02; 54:138-148. PMID: 29248537.
      View in: PubMed
    6. Harris J, Herrero-Garcia E, Russo A, Kajdacsy-Balla A, O'Bryan JP, Chiu B. Silencing Intersectin 1 Slows Orthotopic Neuroblastoma Growth in Mice. J Pediatr Hematol Oncol. 2017 11; 39(8):e413-e418. PMID: 28787396.
      View in: PubMed
    7. Spencer-Smith R, Li L, Prasad S, Koide A, Koide S, O'Bryan JP. Targeting the a4-a5 interface of RAS results in multiple levels of inhibition. Small GTPases. 2017 Jul 10; 1-10. PMID: 28692342.
      View in: PubMed
    8. Spencer-Smith R, Koide A, Zhou Y, Eguchi RR, Sha F, Gajwani P, Santana D, Gupta A, Jacobs M, Herrero-Garcia E, Cobbert J, Lavoie H, Smith M, Rajakulendran T, Dowdell E, Okur MN, Dementieva I, Sicheri F, Therrien M, Hancock JF, Ikura M, Koide S, O'Bryan JP. Inhibition of RAS function through targeting an allosteric regulatory site. Nat Chem Biol. 2017 Jan; 13(1):62-68. PMID: 27820802.
      View in: PubMed
    9. Herrero-Garcia E, O'Bryan JP. Intersectin scaffold proteins and their role in cell signaling and endocytosis. Biochim Biophys Acta Mol Cell Res. 2017 Jan; 1864(1):23-30. PMID: 27746143.
      View in: PubMed
    10. Burmeister BT, Wang L, Gold MG, Skidgel RA, O'Bryan JP, Carnegie GK. Protein Kinase A (PKA) Phosphorylation of Shp2 Protein Inhibits Its Phosphatase Activity and Modulates Ligand Specificity. J Biol Chem. 2015 May 08; 290(19):12058-67. PMID: 25802336.
      View in: PubMed
    11. Wang L, Burmeister BT, Johnson KR, Baillie GS, Karginov AV, Skidgel RA, O'Bryan JP, Carnegie GK. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy. Cell Signal. 2015 May; 27(5):908-22. PMID: 25683917.
      View in: PubMed
    12. Russo A, Okur MN, Bosland M, O'Bryan JP. Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2ß) isoform contributes to neuroblastoma tumorigenesis. Cancer Lett. 2015 Apr 10; 359(2):262-8. PMID: 25622909.
      View in: PubMed
    13. Okur MN, Russo A, O'Bryan JP. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase. Mol Cell Biol. 2014 Jan; 34(2):271-9. PMID: 24216759.
      View in: PubMed
    14. Busciglio J, Capone G, O'Bryan J, O'Byran JP, Gardiner KJ. Down syndrome: genes, model systems, and progress towards pharmacotherapies and clinical trials for cognitive deficits. Cytogenet Genome Res. 2013; 141(4):260-71. PMID: 24008277.
      View in: PubMed
    15. Hunter MP, Russo A, O'Bryan JP. Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways. Int J Mol Sci. 2013 Apr 10; 14(4):7829-52. PMID: 23574942.
      View in: PubMed
    16. Wong KA, Russo A, Wang X, Chen YJ, Lavie A, O'Bryan JP. A new dimension to Ras function: a novel role for nucleotide-free Ras in Class II phosphatidylinositol 3-kinase beta (PI3KC2ß) regulation. PLoS One. 2012; 7(9):e45360. PMID: 23028960.
      View in: PubMed
    17. Wong KA, Wilson J, Russo A, Wang L, Okur MN, Wang X, Martin NP, Scappini E, Carnegie GK, O'Bryan JP. Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. PLoS One. 2012; 7(4):e36023. PMID: 22558309.
      View in: PubMed
    18. Russo A, O'Bryan JP. Intersectin 1 is required for neuroblastoma tumorigenesis. Oncogene. 2012 Nov 15; 31(46):4828-34. PMID: 22266851.
      View in: PubMed
    19. Elsherif L, Wang X, Grachoff M, Wolska BM, Geenen DL, O'Bryan JP. Cardiac-specific expression of the tetracycline transactivator confers increased heart function and survival following ischemia reperfusion injury. PLoS One. 2012; 7(1):e30129. PMID: 22272284.
      View in: PubMed
    20. Okur MN, Ooi J, Fong CW, Martinez N, Garcia-Dominguez C, Rojas JM, Guy G, O'Bryan JP. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction. Mol Cell Biol. 2012 Feb; 32(4):817-25. PMID: 22158968.
      View in: PubMed
    21. Hunter MP, Nelson M, Kurzer M, Wang X, Kryscio RJ, Head E, Pinna G, O'Bryan JP. Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome. Neuroreport. 2011 Oct 26; 22(15):767-72. PMID: 21876463.
      View in: PubMed
    22. Place AT, Chen Z, Bakhshi FR, Liu G, O'Bryan JP, Minshall RD. Cooperative role of caveolin-1 and C-terminal Src kinase binding protein in C-terminal Src kinase-mediated negative regulation of c-Src. Mol Pharmacol. 2011 Oct; 80(4):665-72. PMID: 21778303.
      View in: PubMed
    23. Wong KA, O'Bryan JP. Bimolecular fluorescence complementation. J Vis Exp. 2011 Apr 15; (50). PMID: 21525844.
      View in: PubMed
    24. O'Bryan JP. Intersecting pathways in cell biology. Sci Signal. 2010 Dec 14; 3(152):re10. PMID: 21156937.
      View in: PubMed
    25. Uchiki T, Kim HT, Zhai B, Gygi SP, Johnston JA, O'Bryan JP, Goldberg AL. The ubiquitin-interacting motif protein, S5a, is ubiquitinated by all types of ubiquitin ligases by a mechanism different from typical substrate recognition. J Biol Chem. 2009 May 08; 284(19):12622-32. PMID: 19240029.
      View in: PubMed
    26. Das M, Scappini E, Martin NP, Wong KA, Dunn S, Chen YJ, Miller SL, Domin J, O'Bryan JP. Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway. Mol Cell Biol. 2007 Nov; 27(22):7906-17. PMID: 17875942.
      View in: PubMed
    27. Scappini E, Koh TW, Martin NP, O'Bryan JP. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase. Hum Mol Genet. 2007 Aug 01; 16(15):1862-71. PMID: 17550941.
      View in: PubMed
    28. Miller SL, Scappini EL, O'Bryan J. Ubiquitin-interacting motifs inhibit aggregation of polyQ-expanded huntingtin. J Biol Chem. 2007 Mar 30; 282(13):10096-103. PMID: 17276991.
      View in: PubMed
    29. Martin NP, Mohney RP, Dunn S, Das M, Scappini E, O'Bryan JP. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling. Mol Pharmacol. 2006 Nov; 70(5):1643-53. PMID: 16914641.
      View in: PubMed
    30. Timsit YE, Miller SL, Mohney RP, O'Bryan JP. The U-box ligase carboxyl-terminus of Hsc 70-interacting protein ubiquitylates Epsin. Biochem Biophys Res Commun. 2005 Mar 11; 328(2):550-9. PMID: 15694383.
      View in: PubMed
    31. Miller SL, Malotky E, O'Bryan JP. Analysis of the role of ubiquitin-interacting motifs in ubiquitin binding and ubiquitylation. J Biol Chem. 2004 Aug 06; 279(32):33528-37. PMID: 15155768.
      View in: PubMed
    32. Richman RW, Tombler E, Lau KK, Anantharam A, Rodriguez J, O'Bryan JP, Diversé-Pierluissi MA. N-type Ca2+ channels as scaffold proteins in the assembly of signaling molecules for GABAB receptor effects. J Biol Chem. 2004 Jun 04; 279(23):24649-58. PMID: 15047708.
      View in: PubMed
    33. Rorie CJ, Thomas VD, Chen P, Pierce HH, O'Bryan JP, Weissman BE. The Ews/Fli-1 fusion gene switches the differentiation program of neuroblastomas to Ewing sarcoma/peripheral primitive neuroectodermal tumors. Cancer Res. 2004 Feb 15; 64(4):1266-77. PMID: 14973077.
      View in: PubMed
    34. Mohney RP, Das M, Bivona TG, Hanes R, Adams AG, Philips MR, O'Bryan JP. Intersectin activates Ras but stimulates transcription through an independent pathway involving JNK. J Biol Chem. 2003 Nov 21; 278(47):47038-45. PMID: 12970366.
      View in: PubMed
    35. Oldham CE, Mohney RP, Miller SL, Hanes RN, O'Bryan JP. The ubiquitin-interacting motifs target the endocytic adaptor protein epsin for ubiquitination. Curr Biol. 2002 Jul 09; 12(13):1112-6. PMID: 12121618.
      View in: PubMed
    36. Storey NM, O'Bryan JP, Armstrong DL. Rac and Rho mediate opposing hormonal regulation of the ether-a-go-go-related potassium channel. Curr Biol. 2002 Jan 08; 12(1):27-33. PMID: 11790300.
      View in: PubMed
    37. O'Bryan JP, Mohney RP, Oldham CE. Mitogenesis and endocytosis: What's at the INTERSECTIoN? Oncogene. 2001 Oct 01; 20(44):6300-8. PMID: 11607832.
      View in: PubMed
    38. Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I, O'Bryan JP, Gupta V, Ratner N, Der CJ, Jacks T, McClatchey AI. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell. 2001 Jul; 1(1):63-72. PMID: 11703924.
      View in: PubMed
    39. O'Bryan JP. Determining involvement of Shc proteins in signaling pathways. Methods Enzymol. 2001; 333:3-15. PMID: 11400346.
      View in: PubMed
    40. Sakai R, Henderson JT, O'Bryan JP, Elia AJ, Saxton TM, Pawson T. The mammalian ShcB and ShcC phosphotyrosine docking proteins function in the maturation of sensory and sympathetic neurons. Neuron. 2000 Dec; 28(3):819-33. PMID: 11163269.
      View in: PubMed
    41. Tong XK, Hussain NK, Adams AG, O'Bryan JP, McPherson PS. Intersectin can regulate the Ras/MAP kinase pathway independent of its role in endocytosis. J Biol Chem. 2000 Sep 22; 275(38):29894-9. PMID: 10896662.
      View in: PubMed
    42. Adams A, Thorn JM, Yamabhai M, Kay BK, O'Bryan JP. Intersectin, an adaptor protein involved in clathrin-mediated endocytosis, activates mitogenic signaling pathways. J Biol Chem. 2000 Sep 01; 275(35):27414-20. PMID: 10851244.
      View in: PubMed
    43. Abe K, Whitehead IP, O'Bryan JP, Der CJ. Involvement of NH(2)-terminal sequences in the negative regulation of Vav signaling and transforming activity. J Biol Chem. 1999 Oct 22; 274(43):30410-8. PMID: 10521418.
      View in: PubMed
    44. O'Bryan JP. The PTB domain: a modular domain with multiple function. Curr Opin Drug Discov Devel. 1999 Sep; 2(5):505-18. PMID: 19649978.
      View in: PubMed
    45. Hussain NK, Yamabhai M, Ramjaun AR, Guy AM, Baranes D, O'Bryan JP, Der CJ, Kay BK, McPherson PS. Splice variants of intersectin are components of the endocytic machinery in neurons and nonneuronal cells. J Biol Chem. 1999 May 28; 274(22):15671-7. PMID: 10336464.
      View in: PubMed
    46. O'Bryan JP, Lambert QT, Der CJ. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor. J Biol Chem. 1998 Aug 07; 273(32):20431-7. PMID: 9685397.
      View in: PubMed
    47. Ganju P, O'Bryan JP, Der C, Winter J, James IF. Differential regulation of SHC proteins by nerve growth factor in sensory neurons and PC12 cells. Eur J Neurosci. 1998 Jun; 10(6):1995-2008. PMID: 9753087.
      View in: PubMed
    48. Biscardi JS, Denhez F, Buehler GF, Chesnutt DA, Baragona SC, O'Bryan JP, Der CJ, Fiordalisi JJ, Fults DW, Maness PF. Rek, a gene expressed in retina and brain, encodes a receptor tyrosine kinase of the Axl/Tyro3 family. J Biol Chem. 1996 Nov 15; 271(46):29049-59. PMID: 8910558.
      View in: PubMed
    49. O'Bryan JP, Martin CB, Songyang Z, Cantley LC, Der CJ. Binding specificity and mutational analysis of the phosphotyrosine binding domain of the brain-specific adaptor protein ShcC. J Biol Chem. 1996 May 17; 271(20):11787-91. PMID: 8662772.
      View in: PubMed
    50. O'Bryan JP, Songyang Z, Cantley L, Der CJ, Pawson T. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. Proc Natl Acad Sci U S A. 1996 Apr 02; 93(7):2729-34. PMID: 8610109.
      View in: PubMed
    51. O'Bryan JP, Fridell YW, Koski R, Varnum B, Liu ET. The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage. J Biol Chem. 1995 Jan 13; 270(2):551-7. PMID: 7822279.
      View in: PubMed
    52. Neubauer A, Fiebeler A, Graham DK, O'Bryan JP, Schmidt CA, Barckow P, Serke S, Siegert W, Snodgrass HR, Huhn D, et al. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood. 1994 Sep 15; 84(6):1931-41. PMID: 7521695.
      View in: PubMed
    53. O'Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa R, Le Beau MM, Earp HS, Liu ET. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol. 1991 Oct; 11(10):5016-31. PMID: 1656220.
      View in: PubMed
    54. Chen L, O'Bryan JP, Smith HS, Liu E. Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization. Oncogene. 1990 Sep; 5(9):1391-5. PMID: 2216462.
      View in: PubMed
    O'Bryan's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _